Article

CURE's Top 5 Stories: July 2019

Here are the top 5 CURE stories for July 2019.

Here are the top 5 CURE stories for July 2019.

5. If Only We Could Freeze Time

Sometimes, life is good and you just want to hit the pause button to enjoy it as much as you can. Here, CURE contributor Jane Biehl writes about how her partial remission makes her want to “freeze time” and prevent change from happening.

4. Biosimilar Approval Offers Options in Blood Cancer

In this story, we cover the FDA’s approval of Ruxience, which could offer a more affordable treatment option for patients with certain types of non-Hodgkin lymphoma and chronic lymphocytic leukemia.

3. A Patient-Turned-Caregiver Shares Her Story

Karen, who received a bladder cancer diagnosis in 2010, was faced with a similar challenge after her husband was diagnosed with the same disease just six years later. Learn more about her experience in this piece.

2. FDA Calls for Breast Implants to Be Recalled

After much debate, earlier this month the FDA requested that the manufacturer of a certain type of implant recall the product to protect women from potential risks, including breast implant-associated lymphoma. Read more in this breaking news coverage.

1. Life Is for Living

Have an adventure, buy the shoes and eat the cake. Here, a patient with glioblastoma shares her thoughts on why she doesn’t let a terminal diagnosis keep her from living her life.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns.
Image of two doctors with text.
Imiage of two doctors with text.
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Image of doctor.
Dr. Massimo Cristofanilli discusses the early use of camizestrant with a CDK4/6 inhibitor to target ESR1 mutations, as it may improve outcomes in metastatic breast cancer.
Image of woman.
Image of man.
Bladder preservation for bladder cancer requires balancing clinical factors and patient health with a personalized treatment plan.
Image of doctor.
Related Content